Trial Profile
Pilot study to evaluate escitalopram in obsessive-compulsive disorder.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Obsessive-compulsive disorders
- Focus Therapeutic Use
- 06 Mar 2012 Actual end date (Mar 2007) added as reported by ClinicalTrials.gov.
- 27 Jul 2007 Status changed from recruiting to completed.
- 02 Nov 2005 New trial record.